UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Psychosocial impact of genetic testing in familial medullary-thyroid carcinoma: A multicentric pilot-evaluation

Annals of oncology, 1999-01, Vol.10 (1), p.87-95

1999

Volltextzugriff (PDF)

Quality of life in patients at risk of medullary thyroid carcinoma and followed by a comprehensive medical network: Trends for future evaluations

Annals of oncology, 2001-10, Vol.12 (10), p.1461-1465

2001

Volltextzugriff (PDF)

Cystic endocrine tumors of the pancreas: clinical, radiologic, and histopathologic features in 13 cases

The American journal of surgical pathology, 2001-06, Vol.25 (6), p.752-760

2001

Volltextzugriff (PDF)

Pharmacokinetic studies in cancer chemotherapy: Usefulness in clinical practice

Cancer treatment reviews, 1997-05, Vol.23 (3), p.153-169

1997

Volltextzugriff (PDF)

The influence of mutation site and age on the severity of duodenal polyposis in patients with familial adenomatous polyposis

Gastrointestinal endoscopy, 2002-03, Vol.55 (3), p.342-347

2002

Volltextzugriff (PDF)

Population pharmacokinetics of doxorubicin, etoposide and ifosfamide in small cell lung cancer patients: results of a multicentre study

British journal of clinical pharmacology, 2000-10, Vol.50 (4), p.315-324

2000

Volltextzugriff (PDF)

Colony-stimulating factors in the prevention of solid tumors induced by chemotherapy in patients with febrile neutropenia

International journal of antimicrobial agents, 1998-04, Vol.10 (1), p.3-9

1998

Volltextzugriff (PDF)

Palliative hormone therapy, low-dose chemotherapy, and bisphosphonate in breast cancer patients with bone marrow involvement and pancytopenia: report of a pilot experience

European journal of internal medicine, 2000-12, Vol.11 (6), p.329-333

2000

Volltextzugriff (PDF)

A limited-sampling strategy for estimation of etoposide pharmacokinetics in cancer patients

Cancer chemotherapy and pharmacology, 1999, Vol.43 (4), p.316-322

1999

Volltextzugriff (PDF)

The prognostic value of etoposide area under the curve (AUC) at first chemotherapy cycle in small cell lung cancer patients: a multicenter study of the groupe Lyon-Saint-Etienne d'Oncologie Thoracique (GLOT)

Lung cancer (Amsterdam, Netherlands), 2001-02, Vol.31 (2-3), p.247-256

2001

Volltextzugriff (PDF)

Therapeutic advances in the management of metastatic colorectal cancer

Expert review of anticancer therapy, 2001-08, Vol.1 (2), p.236-246

2001

Volltextzugriff (PDF)

Dose intensity of chemotherapy in small-cell lung carcinoma

Bulletin du cancer, 2001-09, Vol.88 (9), p.863

2001

Volltextzugriff (PDF)

Primary peritoneal tumors: report on a series of eight cases and review of the literature

Bulletin du cancer, 2002-04, Vol.89 (4), p.430

2002

Volltextzugriff (PDF)

125 The high pharmacokinetic variability of adriamycin, etoposide and ifosfamide among small cell lung cancer patients

Lung cancer (Amsterdam, Netherlands), 1997-08, Vol.18, p.34-35

1997

Volltextzugriff (PDF)

Neurosarcoma associated with neurofibromatosis 1. Apropos of a case and review of the literature

La Presse médicale (1983), 1997-03, Vol.26 (10), p.458-463

1997

Volltextzugriff (PDF)

Neurosarcome associé à une neurofibromatose de type 1:A propos d'un cas et revue de la littérature

La Presse médicale (1983), 1997, Vol.26 (10), p.458-463

1997

Volltextzugriff (PDF)

Progress in the proxifan class: heterocyclic congeners as novel potent and selective histamine H 3-receptor antagonists

European journal of pharmaceutical sciences, 2002-05, Vol.15 (4), p.367-378

2002

Volltextzugriff (PDF)

New Histamine H3-Receptor Ligands of the Proxifan Series: Imoproxifan and Other Selective Antagonists with High Oral in Vivo Potency

Journal of medicinal chemistry, 2000-08, Vol.43 (17), p.3335-3343

2000

Volltextzugriff (PDF)

Novel Histamine H3-Receptor Antagonists with Carbonyl-Substituted 4-(3-(Phenoxy)propyl)-1H-imidazole Structures like Ciproxifan and Related Compounds

Journal of medicinal chemistry, 2000-10, Vol.43 (21), p.3987-3994

2000

Volltextzugriff (PDF)

New Histamine H 3 -Receptor Ligands of the Proxifan Series: Imoproxifan and Other Selective Antagonists with High Oral in Vivo Potency

Journal of medicinal chemistry, 2000-08, Vol.43 (17), p.3335-3343

2000

Volltextzugriff (PDF)

A Novel Series of (Phenoxyalkyl)imidazoles as Potent H 3 -Receptor Histamine Antagonists

Journal of medicinal chemistry, 1996-09, Vol.39 (19), p.3806-3813

1996

Volltextzugriff (PDF)

A Novel Series of (Phenoxyalkyl)imidazoles as Potent H3-Receptor Histamine Antagonists

Journal of medicinal chemistry, 1996-09, Vol.39 (19), p.3806-3813

1996

Volltextzugriff (PDF)

Analogues and derivatives of ciproxifan, a novel prototype for generating potent histamine H 3-receptor antagonists

Bioorganic & medicinal chemistry letters, 2000-10, Vol.10 (20), p.2379-2382

2000

Volltextzugriff (PDF)

Benzophenone Derivatives and Related Compounds as Potent Histamine H3-Receptor Antagonists and Potential PET/SPECT Ligands

Archiv der Pharmazie (Weinheim), 2001-02, Vol.334 (2), p.45-52

2001

Volltextzugriff (PDF)

Analogues and derivatives of ciproxifan, a novel prototype for generating potent histamine H3-Receptor antagonists

Bioorganic & medicinal chemistry letters, 2000-10, Vol.10 (20), p.2379-2382

2000

Volltextzugriff (PDF)

1 – 25 von 32

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(31)
Mit Volltextzugriff
(27)

Publikationsform

Artikel
(32)

Sprache

Englisch
(27)
Französisch
(6)

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(15)
Science & Technology
(15)
Biological And Medical Sciences
(14)
Medical Sciences
(14)
Humans
(13)
Pharmacology. Drug Treatments
(10)
Female
(8)
Male
(8)
Middle Aged
(8)
Adult
(7)
Chemotherapy
(7)
Oncology
(7)
Pharmacology & Pharmacy
(7)
Aged
(6)
Animals
(5)
Histamine Antagonists - Chemical Synthesis
(5)
Histamine Antagonists - Pharmacology
(5)
Neuropharmacology
(5)
Neurotransmitters. Neurotransmission. Receptors
(5)
Rats
(5)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Psychosocial impact of genetic testing in familial medullary-thyroid carcinoma: A multicentric pilot-evaluation

Quality of life in patients at risk of medullary thyroid carcinoma and followed by a comprehensive medical network: Trends for future evaluations

Cystic endocrine tumors of the pancreas: clinical, radiologic, and histopathologic features in 13 cases

Pharmacokinetic studies in cancer chemotherapy: Usefulness in clinical practice

The influence of mutation site and age on the severity of duodenal polyposis in patients with familial adenomatous polyposis

Population pharmacokinetics of doxorubicin, etoposide and ifosfamide in small cell lung cancer patients: results of a multicentre study

Colony-stimulating factors in the prevention of solid tumors induced by chemotherapy in patients with febrile neutropenia

Palliative hormone therapy, low-dose chemotherapy, and bisphosphonate in breast cancer patients with bone marrow involvement and pancytopenia: report of a pilot experience

A limited-sampling strategy for estimation of etoposide pharmacokinetics in cancer patients

The prognostic value of etoposide area under the curve (AUC) at first chemotherapy cycle in small cell lung cancer patients: a multicenter study of the groupe Lyon-Saint-Etienne d'Oncologie Thoracique (GLOT)

Therapeutic advances in the management of metastatic colorectal cancer

Dose intensity of chemotherapy in small-cell lung carcinoma

Primary peritoneal tumors: report on a series of eight cases and review of the literature

125 The high pharmacokinetic variability of adriamycin, etoposide and ifosfamide among small cell lung cancer patients

Neurosarcoma associated with neurofibromatosis 1. Apropos of a case and review of the literature

Neurosarcome associé à une neurofibromatose de type 1:A propos d'un cas et revue de la littérature

Progress in the proxifan class: heterocyclic congeners as novel potent and selective histamine H 3-receptor antagonists

New Histamine H3-Receptor Ligands of the Proxifan Series: Imoproxifan and Other Selective Antagonists with High Oral in Vivo Potency

Novel Histamine H3-Receptor Antagonists with Carbonyl-Substituted 4-(3-(Phenoxy)propyl)-1H-imidazole Structures like Ciproxifan and Related Compounds

New Histamine H 3 -Receptor Ligands of the Proxifan Series: Imoproxifan and Other Selective Antagonists with High Oral in Vivo Potency

A Novel Series of (Phenoxyalkyl)imidazoles as Potent H 3 -Receptor Histamine Antagonists

A Novel Series of (Phenoxyalkyl)imidazoles as Potent H3-Receptor Histamine Antagonists

Analogues and derivatives of ciproxifan, a novel prototype for generating potent histamine H 3-receptor antagonists

Benzophenone Derivatives and Related Compounds as Potent Histamine H3-Receptor Antagonists and Potential PET/SPECT Ligands

Analogues and derivatives of ciproxifan, a novel prototype for generating potent histamine H3-Receptor antagonists

Suchergebnisse filtern